[CAS NO. 1252594-99-2] ETP-46321
PRODUCTS SPECIFICATIONS [1252594-99-2]
DESCRIPTION [1252594-99-2]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 473.55 |
| Molecular Formula | C20H27N9O3S |
| SMILES | NC(N=C1)=NC=C1C2=CN3C=C(CN4CCN(S(=O)(C)=O)CC4)N=C3C(N5CCOCC5)=N2 |
Summary
IC50 & Target
|
p110α 2.3 nM (Ki) |
PI3Kα-E545K 1.77 nM (Ki) |
PI3Kα-E542K 1.89 nM (Ki) |
PI3Kα-H1047R 2.33 nM (Ki) |
p110δ 14.2 nM (Ki) |
p110β 170 nM (Ki) |
p110γ 179 nM (Ki) |
In Vitro
ETP-46321 is selected to be screened against other PI3K isoforms. ETP-46321 is more potent against isoform α (K iapp =2.3 nM). ETP-4632, has been profiled and shown to be a potent PI3K α and δ inhibitor, highly selective versus mTOR and 288 representative kinases. ETP-46321 is also tested against three of the p110α mutant enzymes detected in human cancers (E542K, E545K and H1047R), being equipotent against these mutants when compared to the wild type protein (K iapp =2.33, 1.77 and 1.89 nM for PI3Kα-H1047R, PI3Kα-E545K and PI3Kα-E542K, respectively). ETP-46321 inhibits the phosphorilation of AKT in U2OS cell line with an IC 50 of 8.3 nM [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
ETP-46321, is selected for in vivo studies based on its appealing pharmacokinetic profile in BALB-C mice, low in vivo Clearance (0.6 L/h/Kg) and good oral bioavailability (90%). ETP-46321 demonstrates a good pharmacokinetic profile in mice and is selected for preliminary in vivo evaluation in a lung tumor mouse model driven by a K-RasG12V oncogenic mutation, showing significant tumor growth inhibition, and reduction of the tumor metabolic activity as measured by positron emission tomography (PET) techniques [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : ≥ 33 mg/mL ( 69.69 mM )
* "≥" means soluble, but saturation unknown.
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.1117 mL | 10.5585 mL | 21.1171 mL |
| 5 mM | 0.4223 mL | 2.1117 mL | 4.2234 mL |
| 10 mM | 0.2112 mL | 1.0559 mL | 2.1117 mL |